Europe Radioactive Tracer Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others)

No. of Pages: 128    |    Report Code: BMIRE00029114    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Radioactive Tracer Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Radioactive Tracer Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Radioactive Tracer Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Prevalence of Chronic Diseases
  • 5.1.2 Increased Use of Nuclear Imaging Techniques
5.2 Market Opportunities
  • 5.2.1 Use of Radioactive Tracers in Cancer Diagnosis
5.3 Future Trends
  • 5.3.1 Short Shelf-Life of Radioactive Tracers
  • 5.3.2 Availability of Substitutes to Nuclear Diagnosti Imaging Procedures
5.4 Impact of Drivers and Restraints

6. Europe Radioactive Tracer Market Regional Analysis

6.1 Europe Radioactive Tracer Market Overview
6.2 Europe Radioactive Tracer Market Revenue 2020-2030 (US$ Million)
6.3 Europe Radioactive Tracer Market Forecast Analysis

7. Europe Radioactive Tracer Market Analysis – by Tracer Type

7.1 Technetium-99m & Tc-97m
  • 7.1.1 Overview
  • 7.1.2 Technetium-99m & Tc-97m: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Iodine-131
  • 7.2.1 Overview
  • 7.2.2 Iodine-131: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Iron-59
  • 7.3.1 Overview
  • 7.3.2 Iron-59: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Lutetium-171
  • 7.4.1 Overview
  • 7.4.2 Lutetium-171: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Rubidium Chloride & Ammonia
  • 7.5.1 Overview
  • 7.5.2 Rubidium Chloride & Ammonia: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Scandium-46
  • 7.6.1 Overview
  • 7.6.2 Scandium-46: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Seaborgium-269
  • 7.7.1 Overview
  • 7.7.2 Seaborgium-269: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Hassium-269
  • 7.8.1 Overview
  • 7.8.2 Hassium-269: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Gallium Citrate Ga 67
  • 7.9.1 Overview
  • 7.9.2 Gallium Citrate Ga 67: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.10 Prostate-Specific Membrane Antigen
  • 7.10.1 Overview
  • 7.10.2 Prostate-Specific Membrane Antigen: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.11 FDDNP & FDOPA
  • 7.11.1 Overview
  • 7.11.2 FDDNP & FDOPA: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.12 Phosphorus-32 & Chromium-51
  • 7.12.1 Overview
  • 7.12.2 Phosphorus-32 & Chromium-51: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.13 Thallium-201
  • 7.13.1 Overview
  • 7.13.2 Thallium-201: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.14 F-18 FDG
  • 7.14.1 Overview
  • 7.14.2 F-18 FDG: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.15 F-18 FAPI
  • 7.15.1 Overview
  • 7.15.2 F-18 FAPI: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.16 Ga-68 FAPI
  • 7.16.1 Overview
  • 7.16.2 Ga-68 FAPI: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.17 F-18 PSMA
  • 7.17.1 Overview
  • 7.17.2 F-18 PSMA: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)
7.18 DOTATOC/DOTANOC/DOTATATE
  • 7.18.1 Overview
  • 7.18.2 DOTATOC/DOTANOC/DOTATATE: Europe Radioactive Tracer Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Radioactive Tracer Market Analysis – by Test Type

8.1 PET
  • 8.1.1 Overview
  • 8.1.2 PET: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.2 SPECT
  • 8.2.1 Overview
  • 8.2.2 SPECT: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)

9. Europe Radioactive Tracer Market Analysis – by Application

9.1 Oncology
  • 9.1.1 Overview
  • 9.1.2 SPECT: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Pulmonary
  • 9.2.1 Overview
  • 9.2.2 SPECT: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Neurology
  • 9.3.1 Overview
  • 9.3.2 SPECT: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiology
  • 9.4.1 Overview
  • 9.4.2 SPECT: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)

10. Europe Radioactive Tracer Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Radioactive Tracer Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 Europe Radioactive Tracer Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 UK: Europe Radioactive Tracer Market Breakdown, by Tracer Type
    • 10.1.1.1.2 UK: Europe Radioactive Tracer Market Breakdown, by Test Type
    • 10.1.1.1.3 UK: Europe Radioactive Tracer Market Breakdown, by Application
  • 10.1.1.2 Germany: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Radioactive Tracer Market Breakdown, by Tracer Type
    • 10.1.1.2.2 Germany: Europe Radioactive Tracer Market Breakdown, by Test Type
    • 10.1.1.2.3 Germany: Europe Radioactive Tracer Market Breakdown, by Application
  • 10.1.1.3 France: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 France: Europe Radioactive Tracer Market Breakdown, by Tracer Type
    • 10.1.1.3.2 France: Europe Radioactive Tracer Market Breakdown, by Test Type
    • 10.1.1.3.3 France: Europe Radioactive Tracer Market Breakdown, by Application
  • 10.1.1.4 Russia: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Radioactive Tracer Market Breakdown, by Tracer Type
    • 10.1.1.4.2 Russia: Europe Radioactive Tracer Market Breakdown, by Test Type
    • 10.1.1.4.3 Russia: Europe Radioactive Tracer Market Breakdown, by Application
  • 10.1.1.5 Italy: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Radioactive Tracer Market Breakdown, by Tracer Type
    • 10.1.1.5.2 Italy: Europe Radioactive Tracer Market Breakdown, by Test Type
    • 10.1.1.5.3 Italy: Europe Radioactive Tracer Market Breakdown, by Application
  • 10.1.1.6 Rest of Europe: Europe Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Radioactive Tracer Market Breakdown, by Tracer Type
    • 10.1.1.6.2 Rest of Europe: Europe Radioactive Tracer Market Breakdown, by Test Type
    • 10.1.1.6.3 Rest of Europe: Europe Radioactive Tracer Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Radioactive Tracer Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Rotem Industries Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 ABX advanced biochemical compounds GmbH
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Invicro LLC
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Cardinal Health Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Newcastle University
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Novartis AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Curium
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Blue Earth Diagnostics Limited
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 General Electric Co
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 IBA Radiopharma Solutions
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Europe Radioactive Tracer Market

  1. Rotem Industries Ltd
  2. ABX advanced biochemical compounds GmbH
  3. Invicro LLC
  4. Cardinal Health Inc
  5. Newcastle University
  6. Novartis AG
  7. Curium
  8. Blue Earth Diagnostics Limited
  9. General Electric Co
  10. IBA Radiopharma Solutions
europe-radioactive-tracer-market